GlaxoSmithKlineThe Impact of Medicines - Annual Review 2002
Reporting Front PageDownloads

Annual Review 2002 home
Chairman and Chief Executive Officer's statement
Patients and product development
R&D productivity
Innovative science
Diseases of the developing world
Our people
Corporate and social responsibility
Product portfolio
The Board
The Corporate Executive Team
Business operating review
Responsibility statement
Corporate governance
Summary financial statement
Summary remuneration report
Shareholder information
Contact details
Contact Details
 
Previous
Next

Internet
Information for investors and about the company is available on GlaxoSmithKline’s corporate website at www.gsk.com

Head Office and Registered Office
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex TW8 9GS
Tel: +44 (0)20 8047 5000

United Kingdom
Investor Relations
980 Great West Road
Brentford
Middlesex TW8 9GS
Tel: +44 (0)20 8047 5557 / 5558
Fax: +44 (0)20 8047 7807

Registrar
Lloyds TSB Registrars
The Causeway
Worthing
West Sussex BN99 6DA
www.shareview.co.uk

General enquiries, Annual Report
orderline and Corporate Nominee service
Tel: 0870 600 3991 inside the UK
Tel: +44 (0)121 415 7067 outside the UK

Shareholder Investment Plans
Dividend Re-investment queries
Tel: 0870 241 3018 inside the UK
Tel: +44 (0)1903 604 516 outside the UK

Monthly Savings Plan queries
Tel: 0870 606 0268 inside the UK
Tel: +44 (0)131 527 3746 outside the UK

ISA enquiries
Tel: 0870 242 4244 inside the UK
Tel: +44 (0)1903 604 594 outside the UK

Glaxo Wellcome and SmithKline Beecham corporate PEPs
The Share Centre Limited
Oxford House
Oxford Road
Aylesbury
Bucks HP21 8SZ
Tel: +44 (0)1296 414 144

Corporate share dealing facility
NatWest Stockbrokers
Corporate and Employee Service
55 Mansell Street
London E1 8AN
Tel: 0870 600 3080 inside the UK
Tel: +44 (0)20 7895 5923 outside the UK
Email: contactces@natwest.com quoting ‘GSK Shareholders Service’

United States of America
Investor Relations
One Franklin Plaza
PO Box 7929
Philadelphia
Tel: 1 888 825 5249 toll free
Tel: +1 215 751 7003 outside the USA
Fax: +1 215 751 3233

ADR programme administrator
The Bank of New York
Shareholder Relations
PO Box 11258
Church Street Station
New York NY 10286-1258
www.adrbny.com
Tel: 1 877 353 1154 toll free
Tel: +1 610 312 5315 outside the USA

Customer Response Center
Tel: 1 888 825 5249 toll free

Produced by Corporate Communications, GlaxoSmithKline plc.
Product names throughout this publication are indicated in italics and are trade marks of GlaxoSmithKline plc, its subsidiaries or associated companies, with the exception of Levitra a trademark of Bayer AG and Nicoderm, a trade mark of Aventis SA, all of which is used under licence by the Group.
 
Previous
Next


Top


Annual Review 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated March 28, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement